This site is intended for healthcare professionals only
LoginRegister
Alembic buys UTI-focused Utility Therapeutics in USD 12 million dealAlembic buys UTI-focused Utility Therapeutics in USD 12 million deal
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Biologics gets EU nod for bone disease treatments, including Osteoporosis, giant cell tumour...
Aurobindo Pharma China Plant incurring loss, break even expected by Q4Aurobindo Pharma arm gets marketing nod for Dazublys from European Commission
Lincoln Pharma to begin API production at Khatraj plant in 1-2 yearsLincoln Pharma to begin API production at Khatraj facility in 1- 2 years
Sun Pharma Names Sana Shaikh as Head of MarketingSun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone...
Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical NegligenceDelhi HC Rejects Modi-Mundipharma's Monopoly Claim Over 'CONTIN', Allows Limited Relief
Natco Pharma unveils Everolimus tablets 1mg in USNatco Pharma sees major leadership exit in RnD, demand & supply, quality
Genmab, AbbVie Face Setback as Epcoritamab Misses Survival Goal in Lymphoma StudyPremarket approval application for Skinvive by Juvederm for neck lines reduction under USFDA review:...
Intas Pharma appoints Udit SakhujaIntas Pharma appoints Udit Sakhuja as Senior General Manager - Global New Product Launch
Rick Suarez Named Head of AstraZenecas US Biopharma Business Amid USD 50 Billion Expansion PlanAstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial Cancer
Roche announces retirement of senior executives Hans Clevers, Barbara SchadlerRoche announces retirement of senior executives Hans Clevers, Barbara Schadler
Puducherry’s Medical Students Join the Fight Against TBDCC Recommends Licensing, Labelling Restrictions on Anti-TB Drugs to Curb Private Market Misuse
X